Recruiting Leukemia Studies in Norwalk
A Long-term Extension Study of PCI-32765 (Ibrutinib)
The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who are currently enrolle...
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
The goal of this Phase 3 clinical trial is study the safety and efficacy of the nextgen anti-CTLA-4 antibody, gotistobart (ONC-392/BNT316), in patients with metastatic non-small cell lung cancer who h...
About Leukemia Clinical Trials in Norwalk
Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.
There are currently 2 leukemia clinical trials recruiting participants in Norwalk, CONNECTICUT. These studies are seeking a combined 1,300 participants. Research is being sponsored by Janssen Research & Development, LLC, OncoC4, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Leukemia Clinical Trials in Norwalk — FAQ
Are there leukemia clinical trials in Norwalk?
Yes, there are 2 leukemia clinical trials currently recruiting in Norwalk, CONNECTICUT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Norwalk?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Norwalk research site will contact you about next steps.
Are clinical trials in Norwalk free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Norwalk studies also compensate for your time and travel.
What leukemia treatments are being tested?
The 2 active trials in Norwalk are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.
Data updated March 2, 2026 from ClinicalTrials.gov